Newton Expands Access to Sequel Everyday Lens Through VSP Managed Vision Care
Friday, October 17 2025 | 08 h 44 min | News
Newton™ (formerly Neurolens) has announced that its Sequel™ everyday lenses are now available through VSP® managed vision care (MVC) plans, extending access to its Convergence Boost™ technology for a wider range of patients experiencing digital eye strain.
According to Newton, digital eye strain affects up to 75% of device users, and the Sequel lens is designed to address this through its proprietary technology that supports more comfortable visual alignment during near tasks. Clinical data from the company suggests that 91% of wearers reported improvement in symptoms commonly associated with digital eye strain, with four out of five recommending the lens.
The Sequel portfolio includes four lens options—Sequel 0, 38, 67, and PAL—allowing practitioners to tailor prescriptions based on patient needs. With inclusion under VSP’s managed care offerings, the company says Sequel transitions from a premium category product to a more accessible solution for everyday wearers.
“VSP availability removes barriers and puts life-changing vision solutions within reach of millions,” said Davis Corley, CEO of Newton. “We’re democratizing access to patented technology that works for the way we live now.”
Optometrist Dr. Paul Lovero noted that patients report reduced visual fatigue and greater comfort with Sequel lenses, describing the experience as “eyes feeling like they’re on vacation.”
While the Sequel range is positioned as an everyday lens option, Newton’s Neurolens products with Contoured Prism technology remain available as a premium therapeutic solution for patients requiring advanced prism correction.
More information is available at www.sequellens.com.
Source : Newton
Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!
